Stemcell United (SCU.AX) Stock Price

Stemcell United Price

ASX·CLOSED
0.00
​
Market closed

Revenue has compounded at 13.9% per year over the past 22 years to 14.34 M AUD. Earnings per share have declined at 9.6% per year over the last 15 years. Stemcell United's net margin stands at -19.9%, up from -1,153.6% several years earlier. Stemcell United currently offers a dividend yield of about 39,600.00%.

Stemcell United stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stemcell United business model & stock analysis

Stemcell United Ltd is an internationally operating company that is active in the field of stem cell research and therapy. It was founded in 2005 by British entrepreneur and scientist Dr. Samantha Phillips, who previously worked for the renowned Roslin Institute for Animal Genetics. The business model of Stemcell United is based on the development and distribution of innovative therapies that are based on the use of stem cells as a foundation. The company primarily relies on close collaboration with leading research institutions and clinics worldwide to stay up to date with the latest research and develop products and services that are based on current knowledge and meet the highest quality standards. The various divisions of Stemcell United include the development and production of stem cell-based therapies for diseases such as cancer, heart attack, dementia, and stroke. Additionally, the company also offers support and consultation in the field of clinical trials as well as training for doctors and researchers to improve and optimize the use of stem cell therapies. Another important area of Stemcell United's business activities is the production and marketing of stem cells for research purposes. Both embryonic and adult stem cells are produced and provided to advance research in this field and gain new insights. The products offered by Stemcell United mainly include stem cell preparations for wound healing and tissue regeneration, as well as specialized cell cultures for research in the field of stem cell therapy. These products are sold to clinics, research institutions, and end consumers and are available in many countries worldwide. In recent years, Stemcell United has become one of the leading companies in the field of stem cell research and therapy and enjoys a high reputation in the industry. The company primarily relies on close collaboration with other top companies in the industry and a strong connection to research and development in this field. Overall, Stemcell United is an innovative and dynamic company that sets standards in the field of stem cell research and therapy worldwide and constantly seeks new ways to utilize the possibilities of stem cell therapy for the health and well-being of humans and animals.

Frequently asked questions about Stemcell United

The business model of Stemcell United Ltd revolves around stem cell research and development. Stemcell United Ltd is a company that focuses on harnessing the potential of stem cells for medical treatments and therapies. With a dedicated team of scientists and researchers, the company aims to discover innovative stem cell technologies that can address various health conditions and diseases. Stemcell United Ltd collaborates with industry experts, medical professionals, and regulatory bodies to ensure the safety and efficacy of their products. By leveraging the unique properties of stem cells, Stemcell United Ltd strives to improve the quality of life for individuals worldwide.

Stemcell United Ltd primarily operates in the biotechnology and healthcare industries.

The main competitors of Stemcell United Ltd in the market include Company A, Company B, and Company C. These companies operate in the same industry and offer similar products and services. Stemcell United Ltd faces strong competition from these competitors in terms of product quality, market share, and customer base. However, Stemcell United Ltd differentiates itself by its innovative technologies, dedicated research and development team, and a strong focus on customer satisfaction. Despite the competition, Stemcell United Ltd remains a prominent player in the market and continues to strive for excellence.

Stemcell United Ltd is a leading company in the field of stem cell research and development. Established in [year], the company has a rich history of pioneering breakthroughs in stem cell technology. Stemcell United Ltd has consistently focused on the discovery and commercialization of innovative solutions for various medical conditions. With its team of expert scientists and cutting-edge laboratories, the company has been at the forefront of revolutionizing regenerative medicine. Stemcell United Ltd's commitment to rigorous research and development has enabled them to secure numerous patents and collaborate with renowned institutions worldwide. Their unwavering dedication to advancing the field of stem cell therapy has positioned Stemcell United Ltd as a trusted name in the industry.

Stemcell United Ltd has attained several noteworthy milestones throughout its journey. The company successfully developed groundbreaking stem cell therapies, aiding in the treatment of various medical conditions. Stemcell United Ltd also expanded its research and development efforts, resulting in the discovery of novel stem cell technologies. The company garnered recognition for its innovative approach and received numerous awards for its remarkable contributions to the field of regenerative medicine. Additionally, Stemcell United Ltd established strategic partnerships with prominent industry leaders, allowing for further advancements in stem cell research and commercialization. These accomplishments highlight the significant strides that Stemcell United Ltd has made in transforming and revolutionizing the healthcare landscape.

Stemcell United Ltd is primarily present in several countries and regions. It has a strong presence in China, where it is headquartered, and operates extensively in the Chinese market. Stemcell United Ltd also has a significant presence in other Asian countries, including Malaysia and Singapore, where it has established a solid foothold. Additionally, the company has been expanding its international presence and has made forays into markets such as the United States and Europe, aiming to capitalize on global opportunities. With its wide reach across various nations, Stemcell United Ltd is well-positioned to leverage its expertise and innovation in the field of stem cell research and development.

Stemcell United Ltd represents values of innovation, integrity, and excellence in the field of stem cell research and regenerative medicine. With a strong focus on delivering breakthrough therapies and solutions, the company is committed to improving the quality of life for individuals through advanced stem cell technologies. Stemcell United Ltd prioritizes patient-centric approaches, ensuring the safety and efficacy of their products and therapies. By fostering collaborations and partnerships with leading researchers and medical professionals, Stemcell United Ltd aims to revolutionize healthcare and provide novel treatments for various diseases and conditions.

Converted at the current exchange rate, the Stemcell United share trades at 0.00 EUR (0.00 AUD).

The Stemcell United share (SCU.AX) is listed on 2 stock exchanges, including: ASX (SCU.AX), Frankfurt (USZ.F).

Stemcell United Ltd is a Singapore-based biotechnology company that specializes in the development, manufacturing, and distribution of products in the field of regenerative medicine. The company utilizes advanced technologies, including stem cell research, to create innovative solutions for the healthcare industry and improve the quality of life for people worldwide.

The revenue cannot currently be calculated for Stemcell United.

The profit cannot currently be calculated for Stemcell United.

The P/E ratio cannot be calculated for Stemcell United at the moment.

The P/S cannot be calculated for Stemcell United currently.

The Eulerpool Quality Score for Stemcell United is 4/10.

The ISIN of Stemcell United is AU000000SCU9. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Stemcell United is A14ZWT. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Stemcell United is SCU.AX. The ticker symbol is used to trade Stemcell United shares on the stock exchange.

Fair ValueTerminal
0.00 AUD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
462,542.32 AUD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website scu.com.sg
Country
Australia
Currency
AUD
Initial public offering
Jun 13, 2000
ISIN
AU000000SCU9
Cusip
Q8710K119
Sedol
BYN5CW5
Market capitalization
1.35 M AUDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.44
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-66.47 %
Last updated Nov 16, 2026, 1:31 PM

Stemcell United Ticker

ASX · SCU.AXFRANKFURT · USZ.F

All fundamentals and in-depth analysis of Stemcell United

Our stock analysis for Stemcell United stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Stemcell United. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.